Mometasone/salicylic acidAlternative Names: Combisor; Mometasone furoate/salicylic acid; Monsalic; Salicylic acid/mometasone; Salicylic acid/mometasone furoate
Latest Information Update: 19 Sep 2013
At a glance
- Originator Schering-Plough
- Developer Merck & Co
- Class Anti-inflammatories; Antipsoriatics; Glucocorticoids; Pregnadienediols; Salicylates
- Mechanism of Action Glucocorticoid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Psoriasis; Skin disorders